ANGIODYNAMICS INC — Director's Dealing 2017

Jan 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2017-01-13

Reporting Person: LaPorte Steve (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-13	Common Stock	M	14000	$15.75	Acquired	48201	Direct
2017-01-13	Common Stock	F	14000	$17.92	Disposed	34201	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-13	Non-Qualified Stock Option (right to buy)	$15.75	M	14000	Disposed	2017-08-03	Common Stock (14000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.89 to $17.99, inclusive. The options exercised to purchase the shares were granted on 8/3/2010 and were set to expire on 8/3/2017. The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.

F2: The options became exercisable as to 4,667 shares on August 3, 2011, 4,667 shares on August 3, 2012 and 4,666 shares on August 3, 2013.